Microbiology testing is used for individuals in order to detect the presence of pathogenic microorganisms and their metabolites. It is growing at a faster pace due to rise in the demand from in-vitro diagnostics industry and for its application to check for impurity or presence of any microorganisms such as yeast, fungi, bacteria, and viruses in a sample. For example, microbiology testing is beneficial for examining the microbial presence in a given sample, for the diagnosis of tuberculosis, syphilis, Ebola virus, HIV and many infectious diseases. It is used in various applications such as healthcare for disease diagnostics, in the food industry for food safety testing especially the canned foods, in the cosmetic industry, and for environmental monitoring. The Food and Drug Administration (FDA) has set scientific standards for microbiology testing in various applications. The companies that manufacture drugs, cosmetics, packaged food items, etc., use these regulatory standards to ensure that their products are safe for human consumption.
Global microbiology testing market can be segmented on the basis of product (consumable and instruments), by microbial testing type (viral, bacterial, and fungal), by applications (traditional, rapid, and molecular) and by end-user (hospitals and academics), and by geography. On the basis of products, the segments are consumables and instruments. Consumables are further divided into reagents and kits. Kits occupy the major market share amongst consumables due to its rise in utility by healthcare and diagnostic centers. Instruments are subdivided into microbiology analyzers, automated microbiology instruments, and microbiology analyzers. It is projected that automated microbiology instruments will experience a rapid growth in the upcoming years. Microbiology analyzers are segmented into microscopes, molecular diagnostic instruments, and mass spectrometers. Mass spectrometers are expected to experience a swift development due to increase in the adoption of the device as well as increasing efficiency. Based on the testing type the microbiology testing can be done for the analysis of bacteria like E. coli, fungi (e.g. mold), and viruses such as HIV and Ebola. It can also be used to detect the presence of endotoxins, mycotoxins, pollen, allergens, and particulates in the air, water, dust, food, and consumer products. On the basis of end-user, the microbiology testing market is segmented into academia and hospitals. Academia includes research laboratories, microbial testing labs, food testing laboratory and pathology labs, while in hospitals microbial testing is used for the diagnosis of respiratory diseases, periodontal diseases, sexually transmitted infections, and urinary tract infections. Respiratory disease segment dominates the market owing to rise in inflammatory diseases as a result of rising population of smokers and increase in pollution level which may lead to certain chronic diseases such as asthma.
Technological developments, growing awareness about preventive medicine, rising incidence of infectious diseases, favorable funding and research grants, growing healthcare expenditure across the world, and public-private investments in the field of life science research & developments are the key market drivers for the microbiology testing industry. Furthermore, improving healthcare infrastructure across the emerging markets demand for advanced molecular diagnostic products. Operational barriers to diagnostic test usage, intense competition among vendors, and bundled sales by market leaders across major markets are the major challenge limiting the growth of the microbiology testing market. However, growing demand for point-of-care (POC) diagnostics is the latest trend being observed in the microbiology testing market.
Geographically, the global microbiology testing market is divided into five regions - North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North-America holds the largest market share in terms of revenue followed by Europe. Rising prevalence of various diseases among the population, refined healthcare infrastructure, and rising need for advanced diagnostic testing are the key reasons accounted for the market growth in North America. Developing economies of Asia Pacific and Latin America such as India, China, and Brazil are expected to experience a rapid expansion due to favorable laws being incorporated in the country, tax benefits, favorable reimbursement scenario, and increasing medical tourism in these nations. Moreover, the rise in prevalence and severity of diseases in emerging nations such as India, China, Indonesia, and Malaysia propels the growth in the region.
Key players involved in the global microbiology testing markets are Bio-Rad Laboratories, Becton Dickinson and Company, Danaher, bioMérieux, and Thermo Fisher Scientific. Other prominent vendors are Abbott Diagnostics, Alcon Laboratories, Cepheid, Cavidi, and many more.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.